What NEONC TECHNOLOGIES HOLDINGS, INC.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 8 | 24 |
| Sells | 0 | 0 |
| Total trades | 9 | 27 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 159,275 | 373,689 |
| Disposed | 0 | 0 |
| Net activity | +159,275 | +373,689 |
Common stock only — 2 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Heshmatpour Amir F | CEO, President | Aug 18 | Open-market buy · P | +9,000 | $5.54 | +$49.9K | 3,096,000 |
| Chen Thomas C | CEO | Aug 18 | Open-market buy · P | +12,757 | $5.49 | +$70K | 13,705 |
| Heshmatpour Amir F | CEO, President | Aug 17 | Open-market buy · P | +3,000 | $4.37 | +$13.1K | 3,087,000 |
| Chen Thomas C | CEO | Aug 17 | Open-market buy · P | +2,472 | $4.04 | +$10K | 583,531 |
| Chen Thomas C | Chief Scientific Officer | Aug 17 | Open-market buy · P | +2,472 | $4.04 | +$10K | 583,531 |
| Heshmatpour Amir F | CEO, President | Aug 14 | Open-market buy · P | +12,000 | $3.79 | +$45.5K | 3,084,000 |
| Chen Thomas C | CEO | Aug 14 | Open-market buy · P | +33,787 | $3.85 | +$130K | 581,059 |
| Chen Thomas C | Chief Scientific Officer | Aug 14 | Open-market buy · P | +33,787 | $3.85 | +$130K | 581,059 |
| Shomali Nasim | Director | Jul 10 | Grant / award · A | +50,000 | — | — | 50,160 |
| Heshmatpour Amir F | President | May 01 | Open-market buy · P | +10,000 | $4.16 | +$41.6K | 3,072,000 |
| Heshmatpour Amir F | President | Apr 28 | Open-market buy · P | +10,000 | $4.52 | +$45.2K | 3,062,000 |
| Chen Thomas C | Chief Scientific Officer | Apr 24 | Open-market buy · P | +10,000 | $4.80 | +$48K | 10,000 |
| Heshmatpour Amir F | President | Apr 23 | Open-market buy · P | +10,000 | $4.90 | +$49K | 3,052,000 |
| Neman-Ebrahim Yousha | Chief Clinical Officer | Apr 23 | Open-market buy · P | +500 | $4.88 | +$2.44K | 134,760 |
| Chen Thomas C | Chief Scientific Officer | Apr 10 | Open-market buy · P | +948 | $5.17 | +$4.9K | 948 |
| Heshmatpour Amir F | President | Apr 10 | Open-market buy · P | +10,000 | $4.90 | +$49K | 3,042,000 |
| Heshmatpour Amir F | President | Apr 09 | Open-market buy · P | +5,000 | $5.19 | +$26K | 3,032,000 |
| SUH, David Jr. | Chief Accounting Officer | Apr 09 | Open-market buy · P | +200 | $5.00 | +$1K | 111,866 |
| Heshmatpour Amir F | President | Apr 08 | Open-market buy · P | +10,000 | $5.61 | +$56.1K | 3,027,000 |
| Heshmatpour Amir F | President | Apr 06 | Open-market buy · P | +5,000 | $6.32 | +$31.6K | 3,017,000 |
Loading...
